| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $84.11M | $89.20M | $67.10M | $32.66M | $16.18M |
| R&D | $59.99M | $63.99M | $46.02M | $23.95M | – |
| SG&A | $24.12M | $25.21M | $21.08M | $8.71M | – |
| Operating Income | -$84.11M | -$89.20M | -$67.10M | -$32.66M | -$16.18M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$77.91M | -$80.56M | -$60.39M | -$31.17M | -$16.24M |
| EPS (basic) | -2.0200 | -2.3800 | -2.7400 | -7.5600 | -9.3200 |
| EPS (diluted) | -2.0200 | -2.3800 | -2.7400 | -7.5600 | -9.3200 |
| Shares (diluted) | $38.51M | $33.79M | $22.08M | $4.12M | $1.74M |